// App-Quantinova.ai

1583 : A Phase 2 Study Of Ruxolitinib In Patients With Splanchnic Vein Thrombosis Associated With Myeloproliferative Neoplasm. Preliminary Results

Researchers

Presenter

  • Lisa Pieri

Principal Investigators

  • Paola Guglielmelli

  • Ilaria Nichele

  • Guido Finazzi

  • Maria Luisa Ferrari

  • Vittorio Rosti

  • Valerio De Stefano

  • Elisa Rumi

  • Carmela Mannarelli

  • Tiziana Fanelli

  • Alberto Bosi

  • Alessandro Rambaldi

  • Rajmonda Fjerza

  • Giovanni Barosi

  • Mario Cazzola

  • Tiziano Barbui

  • Alessandro M. Vannucchi

  • Umberto Arena

  • Fabio Marra

  • Stefano Colagrande

  • Fabio Mori

  • Roberto Marchioli

  • Raffaella Pioggiarella

  • Marco Ruggeri

Medical Centers

  • Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy

  • Institute of Hematology, Catholic University, Rome, Italy

  • Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

  • Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Endocrinology Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy

  • Internal Medicine and Hepatology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy

  • Hematology, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy

  • Fondazione Mario Negri Sud, S. Maria Imbaro, Italy

  • USC Ematologia, Ospedale Papa Giovanni XXIII, Bergamo,

  • San Bortolo General Hospital, Vicenza, Italy

  • Istituto Mario Negri Sud, Santa Maria Imbaro, Italy

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

  • University of Florence, Florence, Italy

  • Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Department of Hematology, Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

  • Radiodiagnostica-, Dip Scienze Biomediche Sperimentali e Cliniche, Azienda Ospedaliera Universitaria Careggi, Florence, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Myeloid neoplasms

  • Extrahepatic portal vein obstruction

  • Essential thrombocythemia

  • Esophageal varices

  • Polycythemia vera

  • Budd-Chiari syndrome

  • Myelofibrosis

  • Shingles

  • Venous thrombosis

  • Anemia

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

  • Ruxolitinib phosphate

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved